"The main objective of our research is to understand better the links between protein dysregulation in the brain and cognitive/béhavioral disorders during ageing. We are also actively contributing to developing innovative methods for brain diagnosis and treatment."
As part of our pilot project to improve the diagnosis of dementia in African countries, Luc Belinga from Richetin Lab spent 1 month in Yaoudé collecting blood from patients diagnosed with Alzheimer's disease.
